A multi-omic landscape of steatosis-to-NASH progression
Life Metabolism · 31.12.2022 · 1 (3) · 242-257
DOI: 10.1093/lifemeta/loac034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Metabolism, online erschienen am 01.12.2022. Verfasst von Liping Xiang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes M…. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Shanghai Municipal Science and Technology Committee.
Abstract (Originalsprache)
Nonalcoholic steatohepatitis (NASH) has emerged as a major cause of liver failure and hepatocellular carcinoma. Investigation into the molecular mechanisms that underlie steatosis-to-NASH progression is key to understanding the development of NASH pathophysiology. Here, we present comprehensive multi-omic profiles of preclinical animal models to identify genes, non-coding RNAs, proteins, and plasma metabolites involved in this progression. In particular, by transcriptomics analysis, we identified Growth Differentiation Factor 3 (GDF3) as a candidate noninvasive biomarker in NASH. Plasma GDF3 levels are associated with hepatic pathological features in patients with NASH, and differences in these levels provide a high diagnostic accuracy of NASH diagnosis (AUROC = 0.90; 95% confidence interval: 0.85−0.95) with a good sensitivity (90.7%) and specificity (86.4%). In addition, by developing integrated proteomic-metabolomic datasets and performing a subsequent pharmacological intervention in a mouse model of NASH, we show that ferroptosis may be a potential target to treat NASH. Moreover, by using competing endogenous RNAs network analysis, we found that several miRNAs, including miR-582-5p and miR-292a-3p, and lncRNAs, including XLOC-085738 and XLOC-041531, are associated with steatosis-to-NASH progression. Collectively, our data provide a valuable resource into the molecular characterization of NASH progression, leading to the novel insight that GDF3 may be a potential noninvasive diagnostic biomarker for NASH while further showing that ferroptosis is a therapeutic target for the disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao…
- Key Laboratory of Metabolism and Molecular Medicine of the Ministry of Education, Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China.
- Department of Oncology, the First Affiliated Hospital of Anhui Medical University, Hefei, China.
- Department of Endocrinology and Metabolism, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Laboratory Animal Science, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Zhongshan Hospital Institute of Clinical Science, Fudan University, Shanghai Institute of Clinical Bioinformatics, Shanghai, China.
ORCID-Profile: Yao Li, Ming-Hua Zheng, Yan Lu
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Shanghai Municipal Science and Technology Committee
- Excellent Youth Cultivation Program of Shanghai Sixth People’s Hospital
- Shenzhen Science and technology R&D Foundation
Zitieren
APA
Xiang, L., Li, X., Luo, Y., Zhou, B., Liu, Y., Li, Y., Wu, D., Jia, L., Zhu, P. W., Zheng, M. H., Wang, H., & Lu, Y. (2022). A multi-omic landscape of steatosis-to-NASH progression. Life Metabolism, 1(3), 242-257. https://doi.org/10.1093/lifemeta/loac034
Vancouver
Xiang L, Li X, Luo Y, Zhou B, Liu Y, Li Y, et al. A multi-omic landscape of steatosis-to-NASH progression. Life Metabolism. 2022;1(3):242-257. doi:10.1093/lifemeta/loac034
BibTeX
@article{Xiang2022,
author = {Xiang, Liping and Li, Xiaoyan and Luo, Yunchen and Zhou, Bing and Liu, Yuejun and Li, Yao and Wu, Duojiao and Jia, Lijing and Zhu, Pei-Wu and Zheng, Ming-Hua and Wang, Hua and Lu, Yan},
title = {A multi-omic landscape of steatosis-to-NASH progression},
journal = {Life Metabolism},
year = {2022},
volume = {1},
number = {3},
pages = {242--257},
doi = {10.1093/lifemeta/loac034}
}
EUVIMED